Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2002

Conditions

Secondary HyperparathyroidismEnd Stage Renal Disease

Interventions

DRUG

paricalcitol injection

Trial Locations (6)

Stanford University Medical Center, Stanford

Miami Children's Hospital, Miami

The Children's Hospital of Buffalo, Buffalo

Texas Children's Hospital, Houston

University of Texas at Houston, Houston

Medical College of Wisconsin, Milwaukee